Abstract CN34
Background
Suicide as a consequence to a cancer diagnosis and treatment perspectives reflects the multitudinous physical, spiritual and psychological distress and sense of hopelessness that the diagnosis can bring.
The aim of this review was to examine the relationship between suicidal behaviour and the associated risk factors that lead patients with digestive cancer to commit it.
Methods
We searched PubMed, PsycINFO, Embase, CINAHL and Web of Science and systematically reviewed the evidence according to PRISMA guidelines for relevant articles on the association between digestive system cancers and suicide outcomes over the last 13 years (2010–2022). Eligible studies were searched in the main scientific databases through January 2, 2023.
Results
The suicide rate among people with digestive cancer was significantly higher in the United States than in Europe. Overall, the studies examined showed that clinical factors (advanced stage of cancer, severe pain, no surgical treatment or chemotherapy, poor prognosis) and demographic factors (older age, male gender, white race, lack of social support) peaked within six months to 2 years after diagnosis in people who committed suicide. The time between surgery and suicide may be influenced by the type of cancer. Patients with pancreatic cancer usually commit suicide within 2-3 months after surgery.
Conclusions
There are many reasons why people commit suicide, right down to the challenges these patients face in mentally adapting to their new condition and physical illness. It is often the result of a complex interplay of risk and protective factors at individual, interpersonal, community and societal levels. To prevent suicide, we need to maximise protective factors such as: increasing mental acceptance to the cancer diagnosis, ensure early palliative care, regularly screen cancer patients for distress and suicide risk, especially at times of increased suicide risk.
Clinical trial identification
Editorial acknowledgement
Funding: This research received no external funding.
Institutional Review Board Statement: Not applicable.
Informed Consent Statement: Not applicable.
Data Availability Statement: Not applicable.
Conflicts of Interest: I declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
CN62 - Trends, clinicopathological features, surgical treatment patterns and prognoses of early-onset versus late-onset gastric cancer: A retrospective cohort study on 18877 patients
Presenter: Yingxue Liu
Session: EONS Poster Display session
Resources:
Abstract
CN63 - Quality of life among parents of children with cancer
Presenter: Abeer Hussain
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN74 - Exploring the correlation between spiritual health, quality of survival, and meaning of life among breast cancer chemotherapy patients
Presenter: Fang Zhao
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN75 - Telehealth interventions and functional outcomes in breast cancer rehabilitation: A systematic review
Presenter: Marco Invernizzi
Session: EONS Poster Display session
Resources:
Abstract
CN76 - A study of sexual dysfunction in Moroccan female survivors of gynaecological cancer: A prospective study about 220 patients
Presenter: Chadia Ezzouitina
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN77 - ‘Eating with others’: Planning, developing and testing a self-management intervention to promote social eating for patients living with and beyond head and neck cancer
Presenter: Mark Dornan
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN79 - Quality-of-Life (QoL) data published by clinical trials supporting drug approvals for renal cell carcinoma (RCC)
Presenter: Rowanne Seadon
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN80 - Why do some patients undergoing laryngectomy for head and neck cancer opt to not reacquire their voice?
Presenter: Miyoko Iwai
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN81 - How to use a theoretical framework to inform intervention development in a breast cancer study?
Presenter: Sek Ying Chair
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN93 - Quality of life scale-based machine learning approach to predict immunotherapy response in patients with advanced non-small cell lung cancer
Presenter: Juanyan Shen
Session: EONS Poster Display session
Resources:
Abstract
Slides